Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Golden Cariboo (CSE:GCC) (OTC:GCCFF) Expands Gold Footprint in BC (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Regen Biopharma Inc (ID) RGBP

Healthcare Biotechnology
Regen BioPharma, Inc. focuses on the development of regenerative medical applications in the United States. The company engages in identifying small molecules that inhibit or express NR2F6, leading to immune cell activation for oncology applications and immune cell suppression for autoimmune diseases. It also develops several products: HemaXellarate, a cellular therapeutic product derived from... see more

Current News ()

Goldman Small Cap Research Publishes New Research Report on Regen BioPharma, Inc.

ACCESS Newswire November 5, 2025

Regen BioPharma Update on Orphan Drug Application for HemaXellerate Will Be Presented At Emerging Growth Conference on September 24, 2025   

GlobeNewswire September 23, 2025

Regen BioPharma Prepares Response For FDA Regarding Its Orphan Drug Application for HemaXellerate

GlobeNewswire September 16, 2025

Regen BioPharma Explores Expanded Use of HemaXellerate for Chemotherapy-Induced Bone Marrow Suppression

GlobeNewswire September 4, 2025

Regen BioPharma Discusses Potential Impact of HemaXellerate on Chemotherapy Treament Market

GlobeNewswire August 15, 2025

Regen BioPharma, Inc. to Seek Orphan Drug Designation for Lead Product

GlobeNewswire July 23, 2025

Goldman Small Cap Research Publishes New Research Report on Regen BioPharma, Inc.

ACCESS Newswire July 17, 2025

Regen BioPharma, Inc. Expands Vision for Phase 1 Clinical Trial of HemaXellerate(TM)

GlobeNewswire November 19, 2024

Regen BioPharma, Inc. to Present at the Emerging Growth Conference on September 25, 2024, At 4 pm Eastern Time

GlobeNewswire September 23, 2024
View More News ››

Opinion & Analysis ()

No current opinion is available.
View More Opinion ››

Bullboard Posts ()

Regen BioPharma Prepares Response For FDA Regarding...

SAN DIEGO, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Regen BioPharma, Inc. (OTC PINK: RGBP) and (OTC PINK: RGBPP) today announced the Company...
AveragePenny - September 16, 2025

Regen BioPharma, Inc. to Present at the Emerging Growth Conf

Regen BioPharma, Inc. invites individual and institutional investors as well as advisors and analysts, to attend its real-time...
averagepennies - December 5, 2023

Regen BioPharma, Inc. Selects Contract Research Organization

SAN DIEGO, Nov. 16, 2023 /PRNewswire/ -- Regen BioPharma, Inc. (OTC PINK: RGBP) (OTC PINK: RGBPP) The Company has...
averagepennies - November 16, 2023

Regen BioPharma, Inc. CEO Outlines Future Steps in CAR T Pro

SAN DIEGO, Nov. 14, 2023 /PRNewswire/ -- Regen BioPharma, Inc. (OTC PINK: RGBP) (OTC PINK: RGBPP) has previously...
averagepennies - November 14, 2023

Regen BioPharma, Inc. CEO Outlines Future Steps in CAR T Pro

SAN DIEGO, Nov. 14, 2023 SAN DIEGO, Nov. 14, 2023 /PRNewswire/ -- Regen BioPharma, Inc. (OTC PINK: RGBP) (OTC PINK: RGBPP) has...
Tdogzz18 - November 14, 2023

Emerging Growth Conference Regen BioPharma Inc. $RGBP

<< View Post To Watch Video >>
stockpickmover1 - November 14, 2023
View more Bullboard ››

Spanish Mountain Gold Ltd.

Spanish Mountain Gold Ltd.

Spanish Mountain Gold Ltd., an exploration and development stage company, engages in the acquisition, exploration, and ...
View More »

Podcasts